Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Material Contracts, 2018

GILEAD SCIENCES, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2018-11-06: Form 10-Q; Exhibit 10.28; Description Gilead Sciences, Inc. Retention Program for Executive Officers.
  • 2018-08-07: Form 8-K; Exhibit 10.1; Description Separation Agreement and Release dated August 6, 2018 between Gilead Sciences, Inc. and John F. Milligan, Ph.D..
  • 2018-08-06: Form 10-Q; Exhibit 10.26; Description Gilead Sciences, Inc. Corporate Bonus Plan, as amended and restated on January 1, 2019.
FiledFormExhibitDescription
2018-11-0610-Q10.28Gilead Sciences, Inc. Retention Program for Executive Officers
2018-08-078-K10.1Separation Agreement and Release dated August 6, 2018 between Gilead Sciences, Inc. and John F. Milligan, Ph.D.
2018-08-0610-Q10.26Gilead Sciences, Inc. Corporate Bonus Plan, as amended and restated on January 1, 2019

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31